STXS — Stereotaxis, Inc.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1289340 ·
Last close
$1.11
Market Cap
$111.22M
52W High
$3.59
52W Low
$1.09
ADV30
518,599
Next earnings
2026-11-16
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 6,291,000 | 3,794,000 | -5,981,000 | -5,861,000 | 54,030,000 | 14,616,000 | 34,432,000 |
| Dec 2025 | 8,642,000 | 4,327,000 | -5,649,000 | -5,531,000 | 52,251,000 | 13,421,000 | 33,530,000 |
| Sep 2025 | 7,464,000 | 4,101,000 | -6,557,000 | -6,463,000 | 45,587,000 | 10,506,000 | 34,053,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-15,348,000
Investing CF
$-172,000
Financing CF
$19,447,000
CapEx
$-151,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.24
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-589,229,000
Inventory
$10,495,000
Receivables
$9,619,000
ST Investments
—
EBIT TTM
$-22,164,000
Pretax Income TTM
$-21,681,000
Interest Exp TTM
—
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$30,068,000
EBITDA
$-18,058,000
Free Cash Flow
$-8,830,500
Enterprise Value
$129,176,808
Total Cash
$10,491,000
Total Debt
$5,173,000
Shares Out
100,202,178
Trailing EPS
$-0.24
Book Value
$0.12
ROE
-184.3%
ROA
-25.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 32,377,000 | -22,112,000 | -21,643,000 | 52,251,000 | 33,530,000 | 18,721,000 | -13,685,000 |
| Dec 2024 | 26,918,000 | -24,739,000 | -24,045,000 | 46,724,000 | 35,292,000 | 11,432,000 | -8,497,000 |
| Dec 2023 | 26,771,000 | -21,839,000 | -20,713,000 | 41,909,000 | 19,989,000 | 21,920,000 | -9,139,000 |
| Dec 2022 | 28,147,000 | -18,776,000 | -18,292,000 | 53,413,000 | 21,484,000 | 31,929,000 | -8,415,000 |
TTM Snapshot
Revenues TTM
$31,196,000
NetIncome TTM
$-21,681,000
OpCashFlow TTM
—
Assets (Latest)
$54,030,000
Forward EPS
$-0.15
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VANI | Vivani Medical, Inc. | $110.95M | $1.23 | — |
| LAKE | LAKELAND INDUSTRIES INC | $100.21M | $10.09 | — |
| LUCD | Lucid Diagnostics Inc. | $124.14M | $0.65 | — |
| PYPD | PolyPid Ltd. | $99.53M | $4.90 | — |
| APYX | Apyx Medical Corp | $99.41M | $2.36 | — |
News headlines (Yahoo Finance, 1h cache)
Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026
2026-09-16 11:59 · Yahoo
University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program
2026-09-03 11:56 · Yahoo
Stereotaxis (STXS) Q2 2026 Earnings Call Transcript
2026-08-18 22:44 · Yahoo
Stereotaxis Q2 Earnings Call Highlights
2026-08-12 03:04 · Yahoo
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates
2026-08-11 21:45 · Yahoo
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates
2026-08-11 20:01 · Yahoo
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
2026-07-21 13:00 · Yahoo
Stereotaxis closes Robocath takeover
2026-07-09 17:00 · Yahoo
University of Szeged Pioneers First Robotic Cardiology Program in Hungary
2026-07-20 12:31 · Yahoo
Can AI Keep ISRG Ahead of Rising Robotic Surgery Competition?
2026-09-14 18:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.